KMT2A and acute myeloid leukemia: Since overexpression of miR-182 inhibited proliferation of leukemic cells but not normal HSPCs, we performed loss of function studies with a miR-182-/- (182KO) mice model 37, 38 to further explore miR-182 function during leukemogenesis using MLL-AF9-transformed AML model 4.